Health care utilization and mortality among elderly patients with myelodysplastic syndromes.
BACKGROUND: Mortality in patients with myelodysplastic syndromes (MDS) is high, and patients are likely to require hospitalizations, emergency department (ED) visits, and transfusions. The relationships between these events and the MDS complications of anemia, neutropenia, and thrombocytopenia are...
Main Authors: | Lindquist, K, Danese, MD, Mikhael, J, Knopf, K, Griffiths, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
by: Griffiths, R, et al.
Published: (2010) -
Bullous pemphigoid in an elderly patient with myelodysplastic syndrome and refractory anemia coupled with excess of blast
by: Lee, Y.Y., et al.
Published: (2011) -
Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare.
by: Griffiths, R, et al.
Published: (2012) -
Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma
by: Griffiths, R, et al.
Published: (2012) -
Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.
by: Griffiths, R, et al.
Published: (2012)